Ovid Therapeutics Inc(NASDAQ:OVID) 
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase III clinical trial for the treatment of angelman syndrome in adults; and ...
Website: http://www.ovidrx.com
Founded: 2014
Full Time Employees: 65
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 0.32
H 0.32
L 0.28
C 0.28
V 363,818
10EMA 0.28
20EMA 0.28
60EMA 0.28
120EMA 0.28
250EMA 0.28